These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35752307)

  • 1. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.
    Evans N; Conley JM; Cardon M; Hartig P; Medlock-Kakaley E; Gray LE
    Toxicol Appl Pharmacol; 2022 Aug; 449():116136. PubMed ID: 35752307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in mouse, rat, and pooled human hepatocytes.
    Heintz MM; Klaren WD; East AW; Haws LC; McGreal SR; Campbell RR; Thompson CM
    Toxicol Sci; 2024 Jun; 200(1):165-182. PubMed ID: 38574381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in wild-type and PPARα knockout mouse hepatocytes.
    Heintz MM; Klaren WD; East AW; Haws LC; McGreal SR; Campbell RR; Thompson CM
    Toxicol Sci; 2024 Jun; 200(1):183-198. PubMed ID: 38574385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
    Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
    Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of Per- and Polyfluorinated Alkyl Substance Induction Equivalency Factors for Humpback Dolphins by Transactivation Potencies of Peroxisome Proliferator-Activated Receptors.
    Sun X; Xie Y; Zhang X; Song J; Wu Y
    Environ Sci Technol; 2023 Mar; 57(9):3713-3721. PubMed ID: 36812292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the mode of action underlying development of liver lesions in mice following oral exposure to HFPO-DA and relevance to humans.
    Heintz MM; Haws LC; Klaunig JE; Cullen JM; Thompson CM
    Toxicol Sci; 2023 Mar; 192(1):15-29. PubMed ID: 36629480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Maternal, Fetal, and Postnatal Effects of Hexafluoropropylene Oxide Dimer Acid (GenX) from Oral Gestational Exposure in Sprague-Dawley Rats.
    Conley JM; Lambright CS; Evans N; Strynar MJ; McCord J; McIntyre BS; Travlos GS; Cardon MC; Medlock-Kakaley E; Hartig PC; Wilson VS; Gray LE
    Environ Health Perspect; 2019 Mar; 127(3):37008. PubMed ID: 30920876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human nuclear receptors by perfluoroalkylated substances (PFAS).
    Behr AC; Plinsch C; Braeuning A; Buhrke T
    Toxicol In Vitro; 2020 Feb; 62():104700. PubMed ID: 31676336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per- and polyfluoroalkyl substances and relevance to human health.
    Rogers JM; Heintz MM; Thompson CM; Haws LC
    Birth Defects Res; 2023 Jun; 115(11):1011-1062. PubMed ID: 37219003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GenX analogs exposure induced greater hepatotoxicity than GenX mainly via activation of PPARα pathway while caused hepatomegaly in the absence of PPARα in female mice.
    Ren W; Wang Z; Guo H; Gou Y; Dai J; Zhou X; Sheng N
    Environ Pollut; 2024 Mar; 344():123314. PubMed ID: 38218542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha.
    Vanden Heuvel JP; Thompson JT; Frame SR; Gillies PJ
    Toxicol Sci; 2006 Aug; 92(2):476-89. PubMed ID: 16731579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legacy and alternative per- and polyfluoroalkyl substances (PFAS) alter the lipid profile of HepaRG cells.
    Kashobwe L; Sadrabadi F; Brunken L; Coelho ACMF; Sandanger TM; Braeuning A; Buhrke T; Öberg M; Hamers T; Leonards PEG
    Toxicology; 2024 Aug; 506():153862. PubMed ID: 38866127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes.
    Sadrabadi F; Alarcan J; Sprenger H; Braeuning A; Buhrke T
    Arch Toxicol; 2024 Feb; 98(2):507-524. PubMed ID: 38117326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
    Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro.
    Nielsen G; Heiger-Bernays WJ; Schlezinger JJ; Webster TF
    Toxicology; 2022 Jan; 465():153024. PubMed ID: 34743024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental toxicity of Nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS).
    Conley JM; Lambright CS; Evans N; Medlock-Kakaley E; Hill D; McCord J; Strynar MJ; Wehmas LC; Hester S; MacMillan DK; Gray LE
    Environ Int; 2022 Feb; 160():107056. PubMed ID: 34952357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
    Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
    Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexafluoropropylene oxide dimer acid (HFPO-DA) induced developmental cardiotoxicity and hepatotoxicity in hatchling chickens: Roles of peroxisome proliferator activated receptor alpha.
    Xu X; Ni H; Guo Y; Lin Y; Ji J; Jin C; Yuan F; Feng M; Ji N; Zheng Y; Jiang Q
    Environ Pollut; 2021 Dec; 290():118112. PubMed ID: 34500398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat.
    Conley JM; Lambright CS; Evans N; McCord J; Strynar MJ; Hill D; Medlock-Kakaley E; Wilson VS; Gray LE
    Environ Int; 2021 Jan; 146():106204. PubMed ID: 33126064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.